LH39 is potentially useful in the study of benign and malignant human vascular disorders, diseases and tumours associated with angiogenesis, epithelial neoplasms, and conditions of tissue regeneration and repair, such as wound healing.
| Inventor | Institute |
|---|---|
| Irene Leigh | Queen Mary University of London |
| Cat. #: | 151287 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology;Tissue-specific biology |
| Application: | IHC ; IP ; WB |
| Target: | Epithelial cell marker |
| Reactivity: | Primate |
| Clone: | LH39 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | LH39 is potentially useful in the study of benign and malignant human vascular disorders, diseases and tumours associated with angiogenesis, epithelial neoplasms, and conditions of tissue regeneration and repair, such as wound healing. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 185 kDa |
| Immunogen: | Cells from a single cell suspension of epidermal cells (obtained from fresh human neonatal foreskin) were lysed in Nonidet P40 in phosphate buffered saline and the insoluble pellet was sonicated to prepare insoluble fractions. |
| Myeloma used: | Sp2/0-Ag14 |
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | '-15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Giehl et al. 2004. Br J Dermatol. 150(4):722-7. PMID: 15099369. Alterations in the basement membrane zone in pili annulati hair follicles as demonstrated by electron microscopy and immunohistochemistry. Passalidou et al. 2003. Br J Cancer. 88(4):553-9. PMID: 12592369. Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma. Passalidou et al. 2002. Br J Cancer. 86(2):244-9. PMID: 11870514. Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Kakolyris et al. 2001. Anticancer Res. 21(6B):4311-6. PMID: 11908685. Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39. Kakolyris et al. 2000. Br J Cancer. 82(4):844-51. PMID: 10732757. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39. Kakolyris et al. 1999. Cancer Res. 59(21):5602-7. PMID: 10554041. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression. Sinclair et al. 1994. Br J Dermatol. 131(4):499-505. PMID: 7524609. The basement membrane zone of the nail. McKay et al. 1994. Burns. 20 Suppl 1:S19-22. PMID: 8198736. Reconstruction of human skin from glycerol-preserved allodermis and cultured keratinocyte sheets. Almeida et al. 1992. J Pathol. 166(3):243-53. PMID: 1517880. Almeida et al. 1992. J Pathol. 166(3):243-53. PMID: 1517880. A novel lamina lucida component of epithelial and endothelial basement membranes detected by LH39 monoclonal antibody. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.